S‐Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP‐glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen
Open Access
- 29 June 2005
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 60 (4) , 423-433
- https://doi.org/10.1111/j.1365-2125.2005.02446.x
Abstract
To characterize the kinetics of S-naproxen ('naproxen') acyl glucuronidation and desmethylnaproxen acyl and phenolic glucuronidation by human liver microsomes and identify the human UGT isoform(s) catalysing these reactions. Naproxen and desmethylnaproxen glucuronidation were investigated using microsomes from six and five livers, respectively. Human recombinant UGTs were screened for activity towards naproxen and desmethylnaproxen. Where significant activity was observed, kinetic parameters were determined. Naproxen and desmethylnaproxen glucuronides were measured by separate high-performance liquid chromatography methods. Naproxen acyl glucuronidation by human liver microsomes followed biphasic kinetics. Mean apparent K(m) values (+/-SD, with 95% confidence interval in parentheses) for the high- and low-affinity components were 29 +/- 13 microm (16, 43) and 473 +/- 108 microm (359, 587), respectively. UGT 1A1, 1A3, 1A6, 1A7, 1A8, 1A9, 1A10 and 2B7 glucuronidated naproxen. UGT2B7 exhibited an apparent K(m) (72 microm) of the same order as the high-affinity human liver microsomal activity, which was inhibited by the UGT2B7 selective 'probe' fluconazole. Although data for desmethylnaproxen phenolic glucuronidation by human liver microsomes were generally adequately fitted to either the single- or two-enzyme Michaelis-Menten equation, model fitting was inconclusive for desmethylnaproxen acyl glucuronidation. UGT 1A1, 1A7, 1A9 and 1A10 catalysed both the phenolic and acyl glucuronidation of desmethylnaproxen, while UGT 1A3, 1A6 and 2B7 formed only the acyl glucuronide. Atypical glucuronidation kinetics were variably observed for naproxen and desmethylnaproxen glucuronidation by the recombinant UGTs. UGT2B7 is responsible for human hepatic naproxen acyl glucuronidation, which is the primary elimination pathway for this drug.Keywords
This publication has 26 references indexed in Scilit:
- HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECIDDrug Metabolism and Disposition, 2004
- Predicting Human Drug Glucuronidation Parameters: Application of In Vitro and In Silico Modeling ApproachesAnnual Review of Pharmacology and Toxicology, 2004
- ISOFORM SELECTIVITY AND KINETICS OF MORPHINE 3- AND 6-GLUCURONIDATION BY HUMAN UDP-GLUCURONOSYLTRANSFERASES: EVIDENCE FOR ATYPICAL GLUCURONIDATION KINETICS BY UGT2B7Drug Metabolism and Disposition, 2003
- In vitro–in vivo correlations for drugs eliminated by glucuronidation: Investigations with the model substrate zidovudineBritish Journal of Clinical Pharmacology, 2002
- The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomesBritish Journal of Clinical Pharmacology, 2001
- Human UDP-Glucuronosyltransferases: Metabolism, Expression, and DiseaseAnnual Review of Pharmacology and Toxicology, 2000
- Cytochromes P450, 1A2, and 2C9 are responsible for the human hepatic O-demethylation of R- and S-naproxenBiochemical Pharmacology, 1996
- Effect of Fluconazole on Zidovudine Pharmacokinetics in Patients Infected with Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1994
- Glucuronidation of Codeine and Morphine in Human Liver and Kidney Microsomes: Effect of InhibitorsBasic & Clinical Pharmacology & Toxicology, 1990
- Negligible excretion of unchanged ketoprofen, naproxen, and probenecid in urineJournal of Pharmaceutical Sciences, 1980